BSE filing, NSE: MUKKA. Summary written from the filing by ALFA Finder's alert engine.
Mukka Proteins Ltd: key numbers
- Share price
- ₹24.19
- Market cap
- ₹725.7 Cr
- Revenue (annual)
- ₹1,449 Cr
- Net profit (annual)
- ₹52.06 Cr
- P/E (TTM)
- 10.5×Sector 26.2×
- Promoter holding
- 73.33%+0.00% QoQ
- FII holding
- 1.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mukka Proteins Ltd
All →Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Mukka Proteins Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Mukka Proteins Production Started
Mukka Proteins Limited announced its subsidiary, United Gulf Fishery Products LLC, has commenced commercial production in Oman. The facility will produce fish meal and oil.
Mukka Proteins Debt & Borrowing: ₹73.58 Cr
Mukka Proteins Limited approved a corporate guarantee and SBLC worth Rs. 73.58 Crore for its subsidiary in Oman. The security supports credit facilities from HDFC Bank.
- Value
- ₹73.58 Cr
Mukka Proteins Credit Rating
CARE Ratings has reaffirmed the credit ratings of Mukka Proteins Ltd at CARE BBB-; Stable / CARE A3.
Mukka Proteins Credit Rating
CARE Ratings reaffirmed the credit ratings for Mukka Proteins Ltd's bank facilities totaling ₹495 Crore and revised the outlook from Negative to Stable.
- Value
- ₹495.0 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.